Progression from first symptom to diagnosis in childhood brain tumours

Sophie Wilne1, Jacqueline Collier, Colin Kennedy

  • 1Department of Paediatric Oncology, Nottingham University Hospitals' NHS Trust Queen's Medical Centre, Nottingham, UK. sophie.wilne@nuh.nhs.uk

Insights

Diagnosing pediatric brain tumors often involves a median of six symptoms, a significant increase from symptom onset. Reducing the 3.3-month diagnostic interval is crucial for timely intervention in children with brain tumors.

Area of Science:

  • Pediatric Neuro-oncology
  • Clinical Neurology
  • Childhood Cancer Research

Background:

  • Delayed diagnosis of pediatric brain tumors impacts patient outcomes.
  • Understanding the progression of clinical features is vital for early detection.

Purpose of the Study:

  • To investigate the evolution of clinical features from symptom onset to diagnosis in children with brain tumors.
  • To identify factors contributing to the delay in diagnosis and suggest methods for shortening this interval.

Main Methods:

  • Retrospective analysis of 139 children diagnosed with brain tumors across four UK pediatric neuro-oncology centers.
  • Detailed documentation of symptoms at onset and diagnosis, and the time interval between them.

Main Results:

  • The median number of symptoms increased from one at onset to six at diagnosis.
  • The median time from symptom onset to diagnosis was 3.3 months.
  • Headache, nausea/vomiting, motor and visual abnormalities, and behavioral changes significantly increased from onset to diagnosis.

Conclusions:

  • A significant evolution of clinical features occurs between symptom onset and diagnosis in pediatric brain tumors.
  • Longer diagnostic delays were associated with specific symptoms like head tilt and cranial nerve palsies.
  • Interventions aimed at recognizing and addressing these evolving symptoms are needed to shorten the time to diagnosis.

Related Concept Videos

Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Brain Abscess l: Introduction01:26

Brain Abscess l: Introduction

A brain abscess is a focal, intracerebral infection characterized by a localized collection of pus within the brain parenchyma, resulting from microbial invasion and the body’s inflammatory response. It progresses through stages: early and late cerebritis, followed by early and late capsule formation, reflecting tissue destruction, immune response, and eventual encapsulation.Etiology and PathogenesisCausative organisms vary with source and host factors, often involving polymicrobial infections,...
Cancers Originate from Somatic Mutations in a Single Cell02:21

Cancers Originate from Somatic Mutations in a Single Cell

Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
Multiple Sclerosis l: Introduction01:19

Multiple Sclerosis l: Introduction

Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...